These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 101189)

  • 21. Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis.
    Greving JP; Vernooij F; Heintz AP; van der Graaf Y; Buskens E
    Gynecol Oncol; 2009 Apr; 113(1):68-74. PubMed ID: 19176236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why managed care should provide supportive therapies for cancer patients.
    Rubenstein SA
    Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
    [No Abstract]   [Full Text] [Related]  

  • 23. Human serum albumin usage in a comprehensive cancer center.
    Forrester L; Ballentine R; Dana WJ
    Contemp Pharm Pract; 1980; 3(3):134-40. PubMed ID: 10247869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proposal for the deinstitutionalization of patients.
    Ward WJ
    Health Care Manage Rev; 1983; 8(2):73-7. PubMed ID: 6408025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
    Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
    Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre].
    Lilliu H; Stevens D; Brun C; Morel J; Pen CL; Bonastre J; Bachelot F; Davesne C; Gentile A; Hirlimann E; Sabourin JC; Berlie J; Rouëssé J
    Bull Cancer; 2002 Jun; 89(6):635-42. PubMed ID: 12135864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulary decision making in a specialty hospital: effective management of potent and costly drug therapies.
    Keating MJ; Dana WJ
    Hosp Formul; 1990 Jun; 25(6):639-44. PubMed ID: 10113244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Costs of initial cancer care and its affecting factors].
    Kim SY; Kim SG; Park JH; Park EC
    J Prev Med Public Health; 2009 Jul; 42(4):243-50. PubMed ID: 19675401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community cancer centers: organization, program and fiscal issues.
    Lee CZ
    Prog Clin Biol Res; 1986; 216():465-71. PubMed ID: 3088600
    [No Abstract]   [Full Text] [Related]  

  • 31. They're measuring the quality of patient care.
    Powers WE
    Am Med News; 1979 Apr; 22(17):suppl 4-5. PubMed ID: 10308881
    [No Abstract]   [Full Text] [Related]  

  • 32. Escalating costs for cancer chemotherapy.
    Nyman JV; Dorr RT; Hall GR
    Am J Hosp Pharm; 1981 Aug; 38(8):1151-4. PubMed ID: 7270558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
    Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
    Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insurance cost crisis. Cancer centers respond with innovative solution.
    Coppinger-Orndoff M
    Adm Radiol; 1989 Mar; 8(3):34-6. PubMed ID: 10292893
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer treatment at home or in the hospital: what are the costs for French public health insurance? Findings of a comprehensive-cancer centre.
    Raphaël R; Yves D; Giselle C; Magali M; Odile CM
    Health Policy; 2005 May; 72(2):141-8. PubMed ID: 15802149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost of medications in the oncology sector in the context of health economics].
    Walter E; Batista A
    Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytostatic therapy in cancer--a SBU report].
    Glimelius B; Nygren P; Lamnevik G
    Lakartidningen; 2001 Apr; 98(16):1905-10. PubMed ID: 11370407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic analysis of cancer treatment costs: another tool for oncology managers.
    Chirikos TN; Ruckdeschel JC; Krischer JP
    J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The cost of chemotherapy].
    Lévy C; Bonastre J
    Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.